Most patients notice appetite reduction within the first 12 weeks of starting GLP-1 medication
The Trump administrations reported plans for the pilot project, which come after it walked back a Biden-era proposal to cover the drugs, include requirements that Medicare plans and state Medicaid programs also provide patients with diet and exercise coaching, according to the Washington Post, which first reported the plans
Individuals with a history of thyroid cancer (semaglutide carries a warning for medullary thyroid carcinoma)
The drug is being developed by Eli Lilly and Company, the same pharmaceutical manufacturer behind tirzepatide (Mounjaro), which has received MHRA approval in the UK for type 2 diabetes and, more recently, for weight management
Persistent lymphadenopathy (3 weeks for neck lumps) requires GP assessment and may warrant suspected cancer pathway referral per NICE NG12
I really trust her judgment